Patents by Inventor Natasha Bolick

Natasha Bolick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277803
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Application
    Filed: May 11, 2023
    Publication date: September 7, 2023
    Applicant: BECTON, DICKINSON AND COMPANY
    Inventors: Joshua HORVATH, Victor POLITIS, Stephen RICHARDS, Ronald PETTIS, Gary SEARLE, Monica RIXMAN SWINNEY, Natasha BOLICK
  • Patent number: 11690973
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: July 4, 2023
    Assignee: Becton, Dickinson and Company
    Inventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
  • Patent number: 11458281
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: October 4, 2022
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
  • Patent number: 9775947
    Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: October 3, 2017
    Assignee: Becton, Dickinson and Company
    Inventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
  • Publication number: 20170203033
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicant: Becton, Dickinson and Company
    Inventors: Joshua HORVATH, Victor POLITIS, Stephen RICHARDS, Ronald PETTIS, Gary SEARLE, Monica RIXMAN SWINNEY, Natasha BOLICK
  • Publication number: 20170035965
    Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.
    Type: Application
    Filed: October 18, 2016
    Publication date: February 9, 2017
    Applicant: Becton, Dickinson and Company
    Inventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
  • Patent number: 9480794
    Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: November 1, 2016
    Assignee: Becton, Dickinson and Company
    Inventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
  • Publication number: 20150051583
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Application
    Filed: January 4, 2013
    Publication date: February 19, 2015
    Inventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
  • Publication number: 20140107613
    Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.
    Type: Application
    Filed: October 9, 2013
    Publication date: April 17, 2014
    Inventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
  • Publication number: 20100298672
    Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from a sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stimulate toxin release based on t
    Type: Application
    Filed: June 25, 2010
    Publication date: November 25, 2010
    Inventors: Robert D. Black, Natasha Bolick
  • Patent number: 7778695
    Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then sti
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: August 17, 2010
    Assignee: Sicel Technologies, Inc.
    Inventors: Robert D. Black, Natasha Bolick
  • Publication number: 20090180962
    Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then sti
    Type: Application
    Filed: February 19, 2009
    Publication date: July 16, 2009
    Inventors: Robert D. Black, Natasha Bolick
  • Patent number: 7510699
    Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then sti
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: March 31, 2009
    Assignee: Sicel Technologies, Inc.
    Inventors: Robert D. Black, Natasha Bolick
  • Publication number: 20040197267
    Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then sti
    Type: Application
    Filed: February 17, 2004
    Publication date: October 7, 2004
    Inventors: Robert D. Black, Natasha Bolick